Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 271 papers

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis

Reiniš J, Petrenko O, Simbrunner B, Hofer BS, Schepis F, Scoppettuolo M, Saltini D, Indulti F, Guasconi T, Albillos A, Téllez L, Villanueva C, Brujats A, Garcia-Pagan JC, Perez-Campuzano V, Hernández-Gea V, Rautou PE, Moga L, Vanwolleghem T, Kwanten WJ, Francque S, Trebicka J, Gu W, Ferstl PG, Gluud LL, Bendtsen F, Møller S, Kubicek S, Mandorfer M, Reiberger T.

J Hepatol 2023, 78(2): 390–400

DOI: 10.1016/j.jhep.2022.09.012

Prognostic and therapeutic significance of microbial cell-free DNA in plasma of people with acute decompensation of cirrhosis

Li B, Hong C, Fan Z, Cai S, He Q, Lan X, Lai Q, Ji Y, Luo W, Li J, Cheng X, Liu M, Gu Y, Lu G, Li S, Wang Y, Weng X, Niu X, Liu Q, Jalan R, Chen J.

J Hepatol 2023, 78(2): 322–332

DOI: 10.1016/j.jhep.2022.10.008

Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis

Zanetto A, Pelizzaro F, Campello E, Bulato C, Balcar L, Gu W, Gavasso S, Saggiorato G, Zeuzem S, Russo FP, Mandorfer M, Reiberger T, Trebicka J, Burra P, Simioni P, Senzolo M.

J Hepatol 2023, 78(2): 301–311

DOI: 10.1016/j.jhep.2022.09.005

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Dold L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, Boesecke C, Wasmuth JC, Bischoff J, Rockstroh JK, Karsdal MA, Spengler U, Trebicka J, Strassburg CP, Leeming DJ, Langhans B.

Hepatology 2023, 77(2): 466–475

DOI: 10.1002/hep.32676

Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV

Dold L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, Boesecke C, Wasmuth JC, Bischoff J, Rockstroh JK, Karsdal MA, Spengler U, Trebicka J, Strassburg CP, Leeming DJ, Langhans B.

BMC Infect Dis 2023, 23(1): 52

DOI: 10.1186/s12879-023-08000-w

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?

Sauerbruch T, Hennenberg M, Trebicka J, Schierwagen R.

Front Med (Lausanne) 2023, 9: 1100966

DOI: 10.3389/fmed.2022.1100966

Editorial: Terlipressin in patients with acute-on-chronic liver failure grade 3-too late?

Trebicka J, Zarbock A.

Aliment Pharmacol Ther 2023, 57(1): 177–178

DOI: 10.1111/apt.17244

Evaluation of CirrhoCare® – A digital health solution for home management of individuals with cirrhosis

Kazankov K, Novelli S, Chatterjee DA, Phillips A, Balaji A, Raja M, Foster G, Tripathi D, Boddu R, Kumar R, Jalan R, Mookerjee RP.

J Hepatol 2023, 78(1): 123–132

DOI: 10.1016/j.jhep.2022.08.034

Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure

Schulz MS, Mengers J, Gu W, Drolz A, Ferstl PG, Amoros A, Uschner FE, Ackermann N, Guttenberg G, Queck A, Brol MJ, Graf C, Stoffers P, de la Vera AL, Cremonese C, Erasmus HP, Welker MW, Grünewaldt A, Arroyo V, Bojunga J, Fernandez J, Zeuzem S, Kluwe J, Peiffer KH, Welsch C, Fuhrmann V, Rohde G, Trebicka J.

Liver Int 2023, 43(1): 180–193

DOI: 10.1111/liv.15343

Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis

Tranah TH, Ballester MP, Carbonell-Asins JA, Ampuero J, Alexandrino G, Caracostea A, Sánchez-Torrijos Y, Thomsen KL, Kerbert AJC, Capilla-Lozano M, Romero-Gómez M, Escudero-García D, Montoliu C, Jalan R, Shawcross DL.

J Hepatol 2022, 77(6): 1554–1563

DOI: 10.1016/j.jhep.2022.07.014

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024